<?xml version="1.0" ?>
<DOC>
   <DOCID>LA011794-0111</DOCID>
   <HEADLINE> BRIEFLY : OTHER NEWS</HEADLINE>
   <TEXT> Eli Lilly &amp; Co . Cutting AIDS Research : The giant pharmaceutical company has halted in-house research on HIV treatments as part of the pharmaceutical company ' s continuing restructuring plans , officials said.The company ' s AIDS and HIV research was limited , with just one potential drug in the first phase of human tests . That study won ' t be abandoned , but Lilly will search for a partner to continue work . &quot; There are other studies that are in the process of being . . . closed_down in_order for us to focus those resources in areas where we feel we have a competitive advantage , &quot; said Carlos Lopez , executive_director of infectious_diseases research for Lilly . The move comes as the Indianapolis-based company tries to shrink its operations and staff to save money .</TEXT>
</DOC>
